Company Profile
Precision BioSciences Stock Price, News & Analysis
Company overview
Business overview
Precision BioSciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Precision BioSciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Precision BioSciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Precision BioSciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Why the stock is moving
DTIL is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Precision BioSciences has turned PBGENE-HBV into the centerpiece of the story. The Phase 1 data, the ongoing ELIMINATE-B trial, and the dose progression across cohorts are the details that matter because they show the gene-editing platform is moving through actual clinical development.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
Source: Precision BioSciences
- 02
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update
Source: Precision BioSciences
- 03
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
Source: Precision BioSciences
- 04
- 05
Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update
Source: Precision BioSciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.